NYMX
Vanguard Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-204,033
| Closed | -$453K | – | 4457 |
|
|
2021
Q1 | $453K | Buy |
204,033
+25,274
| +14% | +$56.1K | ﹤0.01% | 4148 |
|
|
2020
Q4 | $443K | Buy |
178,759
+25,984
| +17% | +$64.4K | ﹤0.01% | 3975 |
|
|
2020
Q3 | $375K | Sell |
152,775
-7,654
| -5% | -$18.8K | ﹤0.01% | 3858 |
|
|
2020
Q2 | $570K | Buy |
+160,429
| New | +$570K | ﹤0.01% | 3739 |
|
|
2019
Q2 | – | Sell |
-92,057
| Closed | -$181K | – | 4190 |
|
|
2019
Q1 | $181K | Sell |
92,057
-362
| -0.4% | -$712 | ﹤0.01% | 3942 |
|
|
2018
Q4 | $121K | Sell |
92,419
-497
| -0.5% | -$651 | ﹤0.01% | 3975 |
|
|
2018
Q3 | $228K | Buy |
92,916
+3,405
| +4% | +$8.36K | ﹤0.01% | 3986 |
|
|
2018
Q2 | $300K | Buy |
89,511
+9,753
| +12% | +$32.7K | ﹤0.01% | 3919 |
|
|
2018
Q1 | $337K | Buy |
79,758
+4,002
| +5% | +$16.9K | ﹤0.01% | 3869 |
|
|
2017
Q4 | $250K | Buy |
75,756
+6,305
| +9% | +$20.8K | ﹤0.01% | 3893 |
|
|
2017
Q3 | $265K | Buy |
69,451
+788
| +1% | +$3.01K | ﹤0.01% | 3862 |
|
|
2017
Q2 | $302K | Buy |
+68,663
| New | +$302K | ﹤0.01% | 3827 |
|